Jessica Tarlov Fails AGAIN When Her BIG 'Democrats Are Going to Win the...
Tulsi Gabbard Spells Out How Intelligence Community Concocted a Fake Narrative and Congres...
Jonathan Turley Says 'Someone's a Liar and Someone's a Felon' After Declassified Trump...
From Bad to WORSE --> Catherine Herridge Just Dropped ANOTHER Bombshell on Eric...
Trump Activates Military Blockade, Issues Final Warning As Navy Clears Strait of Hormuz...
'You Guys Turn a Blind Eye': Black Woman Takes Democrat Ro Khanna APART...
James Clapper Analyzing the Trump Whistleblower Complaint in 2019 Now Makes People Wonder...
ABC's Good Morning America Didn't Think This Aspect of the Eric Swalwell Story...
*SNORT* Just Found the MOTHER of All Foreshadowing Pic-Posts from Eric Swalwell and...
YO Cali? They BOTH Suck: Katie Porter Trips SPECTACULARLY During Bizarre Victory Lap...
Catherine Herridge Shares Declassified Doc Drop (Adam Schiff Told HUGE Lies About Trump...
Oh, Honey... WAT? Hack Journo Drops the MOST Pathetic Excuse YET for Not...
Barack Obama and Hillary Clinton Just Made the Left's Definition of 'Democracy' VERY...
Monday Morning Meme Madness
Slant Rant: 'Journalist' Jim Acosta Laments Not Being More Opinionated About Trump on...

Christina Pushaw busts the AP for acknowledging a COVID treatment fact they shamed Ron DeSantis for pointing out just a few months ago

Yesterday, the Associated Press’ Matthew Perrone reported a possible setback for a couple of COVID19 treatments, including Regeneron.

Advertisement

More from the AP:

As strained U.S. hospitals brace for a new surge of COVID-19 cases caused by the fast-spreading omicron variant, doctors are warning of yet another challenge: the two standard drugs they’ve used to fight infections are unlikely to work against the new strain.

For more than a year antibody drugs from Regeneron and Eli Lilly have been the go-to treatments for early COVID-19, thanks to their ability to head off severe disease and keep patients out of the hospital.

But both drugmakers recently warned that laboratory testing suggests their therapies will be much less potent against omicron, which contains dozens of mutations that make it harder for antibodies to attack the virus. And while the companies say they can quickly develop new omicron-targeting antibodies, those aren’t expected to launch for at least several months.

The fact that Regeneron may not be as effective against the omicron variant as it’s been against others is noteworthy enough. But Gov. Ron DeSantis’ press secretary Christina Pushaw finds something else noteworthy, too:

Things sure have changed, haven’t they? Recall this past August, when the AP was entertaining the idea that DeSantis was promoting sketchy Regeneron in some kind of quid pro quo scheme because one of his top donors had invested money in Regeneron, making DeSantis shady AF and not to be trusted.

Advertisement

Pushaw called out the AP then.

Just like she’s calling out the AP now.

We’ve got whiplash.

And Pushaw’s got one last question for the AP:

Join the conversation as a VIP Member

Recommended

Trending on Twitchy Videos

Advertisement
Advertisement
Advertisement